SCHEMBL29772289

SCHEMBL29772289

CNc1ccc2ccc(OC[C@H]3O[C@@H](n4cc(C5CCCC5)c5c(N)ncnc54)[C@H](O)[C@@H]3O)cc2n1

nearest known ligand 0.98

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 15/20 0.98
▸ PRMT5 O14744 15/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23273845 1.00 METTL3 (0.98) METTL3PRMT5
SCHEMBL25015662 1.00 METTL3 (0.98) METTL3PRMT5
SCHEMBL23313940 0.99 METTL3 (1.00) METTL3PRMT5
SCHEMBL23313197 0.95 PRMT5 (1.00) METTL3PRMT5
SCHEMBL23313943 0.93 METTL3 (0.86) METTL3PRMT5
SCHEMBL23313226 0.92 PRMT5 (1.00) METTL3PRMT5
SCHEMBL25016870 0.92 PRMT5 (1.00) METTL3PRMT5
SCHEMBL23313100 0.90 METTL3 (1.00) METTL3PRMT5
SCHEMBL23273743 0.89 METTL3 (1.00) METTL3PRMT5
SCHEMBL23313257 0.89 METTL3 (1.00) METTL3PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4048674-A2 METTL3 MODULATORS Accent Therapeutics, Inc. (US) 2022-08-31 — — EP disclosed
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
Send feedback